vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and FVCBankcorp, Inc. (FVCB). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $16.9M, roughly 1.5× FVCBankcorp, Inc.). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
CBLL vs FVCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $16.9M |
| Net Profit | $-13.5M | — |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | 43.7% |
| Net Margin | -54.6% | — |
| Revenue YoY | — | 4377.5% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.35 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $16.9M | ||
| Q3 25 | $22.6M | $416.0K | ||
| Q2 25 | $21.2M | $15.8M | ||
| Q1 25 | $20.5M | $382.0K | ||
| Q4 24 | — | $378.0K | ||
| Q3 24 | $17.2M | $412.0K | ||
| Q2 24 | — | $415.0K | ||
| Q1 24 | — | $359.0K |
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $5.6M | ||
| Q2 25 | $-13.6M | $5.7M | ||
| Q1 25 | $-12.8M | $5.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-10.4M | $4.7M | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $1.3M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | 43.7% | ||
| Q3 25 | -64.8% | — | ||
| Q2 25 | -70.5% | 45.9% | ||
| Q1 25 | -69.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | 1341.1% | ||
| Q2 25 | -64.4% | 36.0% | ||
| Q1 25 | -62.4% | 1352.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -60.6% | 1133.3% | ||
| Q2 24 | — | 1001.2% | ||
| Q1 24 | — | 373.3% |
| Q4 25 | $-0.35 | $0.31 | ||
| Q3 25 | $-0.37 | $0.31 | ||
| Q2 25 | $-0.38 | $0.31 | ||
| Q1 25 | $-0.36 | $0.28 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | $-1.85 | $0.25 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $253.6M |
| Total Assets | $195.8M | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $155.3M | $253.6M | ||
| Q3 25 | $164.1M | $249.8M | ||
| Q2 25 | $172.2M | $243.2M | ||
| Q1 25 | $180.9M | $242.3M | ||
| Q4 24 | — | $235.4M | ||
| Q3 24 | $-136.0M | $230.8M | ||
| Q2 24 | — | $226.5M | ||
| Q1 24 | — | $220.7M |
| Q4 25 | $195.8M | $2.3B | ||
| Q3 25 | $199.5M | $2.3B | ||
| Q2 25 | $207.7M | $2.2B | ||
| Q1 25 | $213.5M | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $47.1M | $2.3B | ||
| Q2 24 | — | $2.3B | ||
| Q1 24 | — | $2.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $23.9M |
| Free Cash FlowOCF − Capex | $-11.0M | $23.8M |
| FCF MarginFCF / Revenue | -44.2% | 140.7% |
| Capex IntensityCapex / Revenue | 0.7% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | $40.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $23.9M | ||
| Q3 25 | $-11.1M | $7.6M | ||
| Q2 25 | $-7.5M | $3.3M | ||
| Q1 25 | $-11.4M | $5.4M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $7.2M |
| Q4 25 | $-11.0M | $23.8M | ||
| Q3 25 | $-11.5M | $7.6M | ||
| Q2 25 | $-7.6M | $3.3M | ||
| Q1 25 | $-11.6M | $5.4M | ||
| Q4 24 | — | $18.1M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $7.1M |
| Q4 25 | -44.2% | 140.7% | ||
| Q3 25 | -50.8% | 1818.0% | ||
| Q2 25 | -35.9% | 20.8% | ||
| Q1 25 | -56.4% | 1413.6% | ||
| Q4 24 | — | 4786.0% | ||
| Q3 24 | — | 1121.8% | ||
| Q2 24 | — | 361.2% | ||
| Q1 24 | — | 1988.3% |
| Q4 25 | 0.7% | 0.3% | ||
| Q3 25 | 1.6% | 0.2% | ||
| Q2 25 | 0.3% | 0.1% | ||
| Q1 25 | 0.7% | 4.2% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | — | 14.1% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 3.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 5.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
FVCB
Segment breakdown not available.
